相关实验视频

Updated: Sep 10, 2025

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

治疗骨转移性疾病的抗吸收剂:巴勒斯坦临床实践中的多中心混合方法研究

Neama Daoud¹, Adan Abu Assa¹, Bayan Abu Obed¹

¹Department of Medicine, Faculty of Medicine and Allied Health Sciences, An-Najah National University, Nablus, Palestine.

|August 27, 2025

概括

对骨转移的抗吸收药物的处方有显著差异. 需要标准化方案来改善患者护理和管理骨转移性疾病的资源使用.

科学领域:

癌症学
药理学
公共卫生

背景情况:

抗吸收药物对于治疗骨转移性疾病,治疗高血症,骨事件和疼痛至关重要.
这项研究调查了巴勒斯坦医疗保健系统中这些药物的处方做法.

研究的目的:

描述巴勒斯坦转移性骨病患者目前的抗吸收药物处方做法.
探讨医疗保健专业人员对这些药物的益处和风险的看法.

主要方法:

一种混合方法方法,将处方数据的回顾性分析与瘤学家和骨科医生的横截面调查相结合.
包括239名转移性骨病患者.

主要成果:

58. 2% 的患者接受了抗吸收药物,使用与癌症和骨转移疾病持续时间有正相关性.
服用这些药物的患者患低血糖的可能性更高 (p=0. 005).
70% 的受访专家更喜欢使用氨酸作为第一线治疗方法,40% 则考虑常规处方.

结论:

对于骨转移的抗吸收剂的处方模式和剂量存在显著的变化.
标准化,基于证据的协议对于优化患者的治疗结果和资源分配至关重要.
未来的研究应评估以患者为中心的结果,长期安全性以及干预措施对实践模式的影响.

关键词:

抗吸收剂癌症发生转移转移性骨疾病癌症学整形医学

更多相关视频

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

相关概念视频

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...